pharma news, views and analysis - pharmaphorum.com

Trending

in News News
Orchard raises $150m to develop gene therapies
August 14, 2018 Share
X
Orchard raises $150m to develop gene therapies
https://pharmaphorum.com/news/orchard-raises-150m-to-develop-gene-therapies/
in News News
Samsung Bioepis and Takeda begin first trial from R&D tie-up
August 13, 2018 Share
X
Samsung Bioepis and Takeda begin first trial from R&D tie-up
https://pharmaphorum.com/news/samsung-bioepis-and-takeda-begin-first-trial-from-rd-tie-up/

Latest News

Sarepta dives deeper into gene therapy

Sarepta dives deeper into gene therapy

Sarepta Therapeutics has handed $30 million to Lacerta in exchange for a group of gene therapies, including a

X

Sarepta dives deeper into gene therapy

https://pharmaphorum.com/news/sarepta-dives-deeper-gene-therapy/

Spark shares tank after haemophilia gene therapy safety signal

Spark shares tank after haemophilia gene therapy safety signal

Biotech still pressing on with late stage trials

X

Spark shares tank after haemophilia gene therapy safety signal

https://pharmaphorum.com/news/spark-shares-tank-after-haemophilia-gene-therapy-safety-signal/

Lundbeck brings third Parkinson’s drug into clinic

Lundbeck brings third Parkinson’s drug into clinic

Denmark’s Lundbeck is bringing a third potential drug for Parkinson’s disease to the clinic – a human antibody

X

Lundbeck brings third Parkinson’s drug into clinic

https://pharmaphorum.com/news/lundbeck-brings-third-parkinsons-drug-into-clinic/

Views & Analysis

Oncolytics: the dawn of a new era in cancer treatment

Oncolytics: the dawn of a new era in cancer treatment

Oncolytic virus therapy is not a new discovery, but it may now be positioned as the next major

X

Oncolytics: the dawn of a new era in cancer treatment

https://pharmaphorum.com/views-and-analysis/oncolytics-new-era-cancer-treatment/

Biosimilar switches and healthcare gains

Biosimilar switches and healthcare gains

Despite being used across Europe for more than a decade, biosimilar medications are still something of a mystery

X

Biosimilar switches and healthcare gains

https://pharmaphorum.com/market-access-2/biosimilar-switches-and-healthcare-gains/

Exclusive Live coverage: Curious2018 Future Insight: Day 3

Exclusive Live coverage: Curious2018 Future Insight: Day 3

Curious2018 – Future Insight is a new flagship healthcare conference launched this year by Merck to bring some

X

Exclusive Live coverage: Curious2018 Future Insight: Day 3

https://pharmaphorum.com/views-and-analysis/exclusive-live-coverage-curious2018-future-insight-day-3/

Debates & Insights

Marketing science – brand innovation for pharma

Combining fields such as economics, statistics and operations research, marketing science has for some time operated under-the-radar as

X

Marketing science – brand innovation for pharma

https://pharmaphorum.com/debates-insight-sales-marketing/marketing-science-brand-innovation-for-pharma/

Digital health: how can technology be used to engage hard-to-reach patients and assist with patient monitoring?

Digital health: how can technology be used to engage hard-to-reach patients and assist with patient monitoring?

Helping someone live with a condition as complex as MS can be fraught with challenges. MS professionals are

X

Digital health: how can technology be used to engage hard-to-reach patients and assist with patient monitoring?

https://pharmaphorum.com/debates-insight-digital/digital-health-can-technology-used-engage-hard-reach-patients-assist-patient-monitoring/

New report: Are clinical trials under threat from ‘system overload’?

New report: Are clinical trials under threat from ‘system overload’?

The 2017 Unified Clinical Operations Survey Report Nearly all (99%) of clinical operations professionals who responded to the

X

New report: Are clinical trials under threat from ‘system overload’?

https://pharmaphorum.com/debates-insight-market-access/new-report-clinical-trials-threat-system-overload/

Partner Content

Industry news with an exclusive interview by from Aerie Pharmaceuticals

Industry news with an exclusive interview by from Aerie Pharmaceuticals

Ophthalmic Drugs

X

Industry news with an exclusive interview by from Aerie Pharmaceuticals

https://pharmaphorum.com/partner-content/industry-news-with-an-exclusive-interview-by-from-aerie-pharmaceuticals/

Talks from the MHRA, Innovate UK, Plasticell and more

Talks from the MHRA, Innovate UK, Plasticell and more

Cell and Gene Therapy

X

Talks from the MHRA, Innovate UK, Plasticell and more

https://pharmaphorum.com/partner-content/talks-from-the-mhra-innovate-uk-plasticell-and-more/

16th Pharmacovigilance 2018

16th Pharmacovigilance 2018

16th Pharmacovigilance 2018 “Ensuring safer drugs to market by analyzing latest developments in pharmacovigilance, drug safety and risk

X

16th Pharmacovigilance 2018

https://pharmaphorum.com/events/16th-pharmacovigilance-2018/

CONTINUE TO SITE >

Close in 10 seconds

Pharmaphorum.com